Therapeutic Solutions International Inc (TSOI) 0.0066

New Post Public Reply Private Reply Replies (0) Message Board

Sep 20, 2016 at 1:21 AM

Therapeutic Solutions International Inc (TSOI) 0.0066 $TSOI

Therapeutic Solutions International Announces New Liposomal Products
Marketwire Canada - Wed Jun 22, 8:02AM CDT
OCEANSIDE, CA--(Marketwired - June 22, 2016) - Therapeutic Solutions International, Inc. (OTC PINK: TSOI) announced today the addition of four new consumer products to our nutraceutical division.

Therapeutic Solutions International's Subsidiary MolecuVax, Inc. Announces Licensing of "Universal Cancer Vaccine" With Demonstrated Efficacy in Breast Cancer
Marketwired - Mon May 09, 8:02AM CDT
Clinical Stage Immunotherapy Company Expands Its Intellectual Property Portfolio by Exclusive Licensing of Issued Patents

Therapeutic Solutions International Files Patent Covering ProJuvenol(C) and Its Active Ingredient Pterostilbene
Marketwired - Thu Apr 28, 8:02AM CDT
Therapeutic Solutions International, Inc., (OTC PINK: TSOI) announced today the filing of a patent application covering the use of ProJuvenolÂ© and its active ingredient pterostilbene for augmentation of stem cell activity. Diseases such as diabetes(1), cardiovascular disease(2), and neurodegenerative diseases(3) are characterized by deficient stem cell activity. The patent covers the stimulation of stem cells that already exist in the patient's body, as well as stem cells that are administered therapeutically.

Therapeutic Solutions International's Subsidiary MolecuVax, Inc. to Initiate Cancer Immunotherapy Clinical Trial Aimed at Eradicating Cancer Stem Cells Using MVAX-001
Marketwired - Mon Apr 11, 8:02AM CDT
Therapeutic Solutions International, Inc., (OTC PINK: TSOI) announced today the signing of an agreement between its subsidiary, MolecuVax, Inc., (MVAX) and the Pan Am Cancer Treatment Center covering production and clinical implementation of a novel cancer immunotherapy based around MVAX's proprietary Brother of the Regulator of Imprinted Sites (BORIS) peptide/exosome technology.

Therapeutic Solutions International Licenses Dexosome Clinical Stage Cancer Immunotherapy Product From Gustave Roussy European Cancer Centre
Marketwired - Mon Jan 25, 8:02AM CST
Therapeutic Solutions International, Inc., (OTC PINK: TSOI) announced today the signing of an exclusive intellectual property license agreement with Gustave Roussy Transfert of Villejuif, France for an issued U.S. patent covering the clinically tested "Dexosome" cancer immunotherapy product.

Therapeutic Solutions International Announces the Appointment of BioPharmaceutical Pioneer Thomas E. Ichim, Ph.D to Board of Directors
Marketwired - Fri Jan 22, 8:00AM CST
Therapeutic Solutions International, Inc., (OTC PINK: TSOI) announced today the appointment of Dr. Thomas E. Ichim to our Board of Directors.

Therapeutic Solutions International Announces the Licensing of Probiotic Technology to OmniBiome, Inc.
Marketwired - Tue Dec 08, 7:55AM CST
Therapeutic Solutions International, Inc. (OTC PINK: TSOI) announced today that the Company has licensed an additional Patent to OmniBiome, Inc. (Omni), a wholly owned subsidiary of Therapeutic Solutions International, Inc., focused on Fetal-Maternal Health.

Therapeutic Solutions International Files Patent on Anticancer Nanotechnology Based Immunotherapy
Marketwired - Mon Nov 23, 7:55AM CST
Therapeutics Solutions International, Inc., (OTC PINK: TSOI) announced today a patent for developing a future generation of immune cell derived nanoparticles, termed exosomes, as a means of selectively stimulating the body's own natural defense mechanisms to seek and destroy cancer cells by company collaborators.

Therapeutic Solutions International Announces the Licensing of Patents to OmniBiome and the Appointment of Iryna Dzieciuch, M.S. as Chief Executive Officer of OmniBiome
Marketwired - Wed Nov 18, 7:55AM CST
Therapeutics Solutions International, Inc. (OTC PINK: TSOI) announced today that the Company has licensed three Patents to OmniBiome, Inc. ("OmniBiome"

a wholly owned subsidiary of Therapeutic Solutions International, Inc. ("TSI"

focused on Fetal-Maternal Health, with the Company's goal to assist women in the treatment or prevention of pre-term birth and pregnancy complications.

Therapeutic Solutions International Announces the Appointment of Michael G. Agadjanyan, Ph.D. to Company Scientific Advisory Board
Marketwired - Mon Oct 19, 7:55AM CDT
Therapeutics Solutions International, Inc., (OTC PINK: TSOI) announced today that Michael Agadjanyan, Ph.D. has been appointed to our Scientific Advisory Board.

Therapeutic Solutions International Announces the Appointment of Harry M. Lander, Ph.D. to the TSI Scientific Advisory Board
Marketwired - Mon Oct 12, 7:55AM CDT
Therapeutics Solutions International, Inc., (OTC PINK: TSOI) announced today that Harry M. Lander, Ph.D. has been appointed to our Scientific Advisory Board.

Therapeutic Solutions International, Inc. Announces the Appointment of Santosh Kesari, M.D., Ph.D. to Company Scientific Advisory Board
Marketwired - Tue Oct 06, 7:50AM CDT
Therapeutics Solutions International, Inc. (OTC PINK: TSOI) announced today that Santosh Kesari, M.D., Ph.D., FANA, FAAN, has been appointed to our Scientific Advisory Board.

Therapeutic Solutions International Files Patent on Immune Therapy Medical Device to Prevent Preterm Labor
Marketwired - Tue Sep 29, 7:50AM CDT
Therapeutics Solutions International, Inc., (OTC PINK: TSOI) announces the filing of U.S. Patent No. 62/232722 titled "A Medical Device For Reducing The Risk Of Preterm-Labor And Preterm-Birth," covering various medical devices aimed at immune modulating the cervical microenvironment in order to prevent preterm labor.

Therapeutic Solutions International Develops Cytokine Based Diagnostic Test for Preterm Labor and Complications of Pregnancy
Marketwired - Mon Sep 21, 8:00AM CDT
Therapeutics Solutions International, Inc. (OTC PINK: TSOI) announced today the development of a cytokine-based diagnostic kit aimed at stratifying risk of preterm labor and other pregnancy associated complications.

Therapeutic Solutions International Announces Engagement With PLS CPA's
Marketwired - Tue Sep 15, 7:45AM CDT
Therapeutics Solutions International, Inc. (OTC PINK: TSOI) announced today the signing of an engagement with PLS CPA, A PC of San Diego CA. On September 10, 2015, Therapeutic Solutions International, Inc. (the "Company"

, approved the engagement of PLS CPA's ("PLS"

as the Company's independent registered public accounting firm beginning with the fiscal year ended December 31, 2013. The engagement of PLS has been approved by the Board of Directors of the Company on September, 10 2015.

Therapeutic Solutions International Files Patient on Cytokine Modulation to Prevent Pregnancy Loss and Pre-Term Labor
Marketwired - Tue Sep 08, 7:45AM CDT
Therapeutics Solutions International, Inc., (OTC PINK: TSOI) announced today the filing of a patent application covering novel means of modulating the immune system to prevent miscarriages and preterm labor. The filed patent covers utility of vaccines and various agents to alter pathological conditions in which the maternal immune system induces a process of inflammation that culminates in placental alterations leading to either fetal loss or preterm labor. To the knowledge of the company, this is one of the only experimental approaches in development for addressing this unmet medical need.

Therapeutic Solutions International Files Patent on Cancer Immune Modulation Using Its ProJuvenol(TM) Product
Marketwired - Thu Jul 09, 7:30AM CDT
Therapeutics Solutions International, Inc., (OTC PINK: TSOI) announced today the filing of a patent application covering the use of its ProJuvenol(TM) product, as well as various pterostilbene compositions, for use in augmenting efficacy of existing immuno-oncology drugs that are currently on the market. The patent is based on the ability of pterostilbene, one of the major ingredients of ProJuvenol(TM), to reduce oxidative stress produced by cancer cells, which in turn protects the immune system from cancer mediated immune suppression.

Therapeutic Solutions Announces Shipping of ProJuvenol(TM) and T-Rx(TM)
Marketwired - Mon May 18, 7:45AM CDT
Therapeutic Solutions International, Inc. (OTC PINK: TSOI) announced today the availability of our flagship product ProJuvenol(TM).

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Nurminen Logistics Doubles Sweden–Italy Rail Capacity

Nurminen Logistics Betting Big on Rail Expansion Feeling the pulse of the logistics world is much like trying to catch lightning in a bottle, but Nurminen Logistics seems to have found its rhythm. They're ramping up their services between Sweden and Italy, leveraging rail to push the envelope. Come October, they're doubling down from one to two weekly departures, giving...

Dr. Liedtka's LIVE Model: Balance Life’s Priorities

Finding Balance in a Chaotic World Forget the market roller coaster for a second. Let's chat about something else that often feels like a roller coaster—life itself. Dr. Karl D. Liedtka's book, "Be Present, LIVE Fully," dives into that hot mess and offers a way to get a grip on your own sanity. This isn't just another self-help book filled with empty platitudes; it's...

Hoymiles' V2X Charger Revamps Home Energy Control

Revolutionizing Home Energy with Hoymiles Here's a twist in the world of home energy that'll make any enthusiast pause—Hoymiles has launched their V2X DC Charger. This little number isn’t just a step up; it’s a giant leap toward integrating electric vehicles (EVs) into your home's energy system like never before. Nestled in Hangzhou, they've rolled this out as a...

AXIS-Y: Global Expansion Fueled by KRW 430B Valuation

Rewriting the Playbook in Global Skincare AXIS-Y decided to do things their way, not just because they could afford to, but because they believed in their vision. Their strategy defies the trends-driven tactics of this cutthroat beauty world. Instead, they’ve been all about climate-inspired products and vegan, cruelty-free standards. And now, after notching up some...

Potensic's ATOM 3 Invites Drone Creators to 'See Beyond'

Innovative Features of Potensic's New Drone Potensic decided to shake things up a bit this year at IFA Berlin, showcasing their new creation: the ATOM 3 drone. Under the theme "SEE BEYOND," Potensic’s message to creators was clear—there’s more to explore in the world of visual storytelling than meets the eye. This drone isn't just another gadget; it's an invitation...

FOTON Accelerates Global Push with European Focus

The Road to Global Dominance Ever feel like someone’s racing past you while others try to catch up? That’s FOTON in the relentless world of commercial vehicles. This juggernaut of a company isn't just satisfied with leading the pack; they’ve got their eyes set on redefines the game, especially with their new moves in Europe. A Shift in Strategy Right now, the...

Supernova SPAC Lawsuit: Settlement Proposed, $3M on Table

Legal Clouds Over Supernova's SPAC Adventure Alright, folks, buckle up, because whenever you mix SPACs and lawsuits, you're in for a roller coaster. Supernova Partners Acquisition Company, Inc. stands right at the heart of a class action lawsuit, and it's been cooking ever since the court in Delaware gave it a nudge forward. Settlement Talk: What's on the Table? So here's...

AION UT Sets New Safety Standard in Euro NCAP 2026

The New Gold Standard in Safety for Small EVs Hop into your favorite auto forum and you'll hear more than a buzz—it's a full-blown ruckus. The reason? GAC’s AION UT just nabbed a 2026 Euro NCAP Five-Star Safety Rating. Now, this isn’t just another accolade in a crowded trophy room; it’s a statement, a seismic shift in how small electric vehicles stack up in terms...

Interventional Ophthalmology: Early Eye Care Strategies Evolve

Proactive Eye Care: The New Frontier Today's eye care landscape is all about catching things early, folks. Long gone are the days of waiting for eyesight to deteriorate before rushing to the nearest eye doc. In Racine, interventional ophthalmology is shifting gears towards preventive care—looking ahead to stop eye diseases in their tracks before they muck up a person's...

AB SKF to Hold EGM, Spin Off Automotive Assets

SKF's Extraordinary Meeting: A Pivotal Moment AB SKF, a heavyweight in the industrial technology sector, is summoning its shareholders for an Extraordinary General Meeting on October 1, 2026. The venue? The Elite Park Avenue Hotel in Gothenburg, Sweden—sounds fancy, but don't expect to hear a string quartet at this shindig. What's truly on the agenda is a critical...